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The Chemistry of Wine
A.L. Waterhouse (Keynote Speaker)
Department of Viticulture and Enology, University of California, One Shields
Ave., Davis, CA 95616-8749
[E-mail: alwaterhouse@ucdavis.edu]
http://waterhouse.ucdavis.edu 
Wine is a very complex fluid, often described as the second most
complex in nature. It contains quite a large number of polyphe-
nolic substances–most of these are derived from the grape, but if
oak is used, this contributes hydrolyzable tannins as well. The
complexity increases with fermentation and aging as the grape
derived phenolics react with the acid and oxygen in wine to pro-
duce many new substances as well, and many of these substances
are poorly characterized at best. The grape derived polyphenolics
are categorized into several groups, and a major distinction are
the flavonoids and non-flavonoids. Among the non-flavonoids,
the hydroxycinnamates constitute the largest group. These are the
major phenolic substances present in the juice of the grape and
this means these are also the principal phenolics in white wine.
These occur as phenolic acids conjugated with tartaric acid, and
during fermentation and aging these conjugates hydrolyze and
partially esterify with the alcohol present in wine. The hydrox-
ycinnamates are also key substrates for polyphenol oxidase, and
are rapidly oxidized if oxygen is present during the crushing
operation. Other non-flavonoids include the benzoic acids, a rel-
atively minor consitituent. Gallic acid is the principal component.
In grapes it occurs as an ester conjugate of epicatechin in seed
condensed tannin, but in the aqueous acidic environment of wine,
is released as the free acid. The stilbenes are also relatively minor
in quantity, but its principal component, resveratrol, appears to
have many important effects on cancer mechanisms, although it
is unclear if the amount in wine could impart any protection
against the disease. The stilbenes occur in the grape mostly as
glucosides, and these conjugates also undergo hydrolysis once
wine is made. The human absorption of resveratrol has been mea-
sured. The absorption and mammalian metabolism of phenolic
substances can be generalized to include the methylation of the
phenolic hydroxyl groups, as well as their glucuronidation and
sulfation. The latter two conversions make polar products likely
to be eliminated, and conversions rates are generally very high
(>90%) except with high doses. In general, absorption rates as
determined by total derived products in the urine is generally 1-
5% of the consumed material. In terms of mass, the flavonoids far
outweigh the non-flavonoids in the grape berry, and these skin
and seed constituents are extracted by the maceration process in
red wine production where these tissues are left in contact with
the fermenting must, and in some cases, the wine after fermenta-
tion, in order to transfer these substances into the wine. The
flavonoids include the flavonols, and of those, quercetin and its
glucosides is the most abundant. As with the other conjugates
mentioned above, these also hydrolyze once wine is made so that
while the grape contains only the glycosides, wine contains these
and the aglycones. These are produced in the grape skin in
response to sunlight, and considering the necessity of sunlight for
high quality fruit, can be used as a marker for red wine quality.
Quercetin is particularly reactive to oxidation, and can be deplet-
ed by oxidative wine treatment. The absorption of quercetin is
enhanced by the presence of glucose as a conjugate, but other
sugars are absorbed like the aglycone. The forms present in plas-
ma and urine are universally converted to the methylated or the
polar conjugates mentioned above. The anthocyanins are the red-
colored pigments in grapes, and they form the basis of red wine
color, reacting with other phenolics in wine to form the poorly
characterized wine pigments. Recent work has began to reveal the
identity of these substances, and there are many different forms
present in wine. Malvidin-3-glucoside is the major anthocyanin
in grapes, with 3 other anthocyanin forms and multiple glycoside
forms. These substances are absorbed and surprisingly, the natur-
al forms are the most abundant observed, although some of the
common conjugates are also detected. The flavanols form the
largest group of polyphenolic in grapes and wine. These include
the monomeric catechins, but the majority exist as the oligomer-
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ic and polymeric forms, variously called the proanthocyanidins
and condensed tannins. These abundant polyphenolics contribute
to the astringent and bitter taste of red wine. They also react with
the anthocyanins over time to produce wine pigments. These
occur mostly in the berry non-conjugated forms, although a small
proportion are esterified to gallic acid. These compounds are
absorbed as the monomers and dimers, but higher oligomers are
not observed intact in the blood or urine. The usual conjugates are
observed and the free flavanols are scarcely measurable. In addi-
tion, the flavonoid structure appears to be extensively degraded
by gut microflora to simple phenolics that are absorbed. It also
appears that the oligomeric and polymeric forms are de-polymer-
ized in the gut by microbial action. Most characterization and
absorption studies have addressed the substances native to the
fresh fruit. The products of processing, both fermentation and
aging, have only been directly investigated in a few cases, such as
wine pigments. From these few lines of study the complexity of
the products is daunting, much as it is with tea and cocoa.
However, to properly understand the physiological effects of
wine polyphenols, these derived substances must not be ignored.
Antioxidants – What They Do and What They Don’t
J.L. Straughan
Division of Pharmacology, Department of Medicine, University of Cape Town.
[E-mail: twoibis@kingsley.co.za]
Antioxidant products abound, and are purveyed to the public-at-
large as providing near-miraculous benefits for the treatment of
almost every ill, as also for the prevention of ill health and for the
maintenance of optimal health. In fact very few clinical studies
have shown anything like significant benefits, and some have
shown that adverse effects can certainly accrue. That these clini-
cal studies have put various antioxidants to the test as though they
are regular allopathic pharmacotherapeutic agents, lies at the
heart of the disappointing and disadvantageous outcomes. We
humans have evolved over the millennia requiring a vast array of
macro- and micro-nutrients along with antioxidant-laden food-
stuffs. Ingesting single isolated antioxidants in large amounts cre-
ates imbalances among these agents within our bodies, which
may well be expected to be un-physiological – we might say
unnatural, and not surprisingly, even deleterious. Only an intake
of a good diet rich in fruits and vegetables and herbs and spices,
along with a better content of omega-3 fatty acids, and avoiding
excess saturated fats and especially trans-fatty acids, seems capa-
ble of providing all essentials for health. It behoves all responsi-
ble healthcare practitioners to counter the ‘hype’ that surrounds
the marketing and use of isolated antioxidants, and to actively
prescribe good diets and wholesome lifestyles. The benefits of
such a lifestyle cannot be mimicked by any ‘pill or potion’.
Red Grape Varieties Differ Both in the Amount and in the
Structure of their Skin and Seed Tannins Extractable from
the Wine
F. Mattivi, U. Vrhovsek, D. Masuero and D. Trainotti
Istituto Agrario di San Michele all’Adige - IASMA, Centro Sperimentale, Via E.
Mach 1, 38010 San Michele all’Adige, Italy
[E-mail: fulvio.mattivi@iasma.it]
Red wine is a very rich source of flavanols, consisting of cate-
chins, oligomeric and polymeric proanthocyanidins (PAs). The
aim of this study was to investigate the composition of the frac-
tion of flavanols which is extractable from the grape into the
wine. By HPLC-DAD-MS analysis, carried out before and after
thioacidolysis, it was confirmed that grape extracts of the vari-
eties Cabernet Sauvignon, Carmenere, Marzemino, Merlot, Pinot
Noir, Syrah and Teroldego are mainly rich in monomers and
small oligomers (mDP < 7). Grape seeds extracts contain three
monomers (catechin, epicatechin and epicatechin gallate) and
procyanidin oligomers. Grape skins extracts contain four
monomers (catechin, epicatechin, gallocatechin and epigallocate-
chin), procyanidins and prodelphinidins oligomers. Upper and
extension units of PAs are constituted mainly or only of epicate-
chin units, in the seeds and skins respectively. The terminal units
of the grape PAs are a mixture of five compounds, the same found
also as monomers. Catechin gallate, gallocatechin gallate and epi-
gallocatechin gallate, which are found in other flavanol-rich,
plant-derived foods and beverages, are not present in grape
extracts. The grape variety determines both the amount and the
structure of wine flavanols, leading to differences in the compo-
sition which are likely to play an important role in the nutritional
and sensorial properties of the wines.
Le vin rouge est un produit très riche en flavanols comprenant les
catéchines et les proanthocyanidines oligomériques et poly-
mériques (PA). L’objectif de cette étude consisitait à examiner la
composition de la fraction de flavanol que l’on peut extraire du
raisin dans le vin. Par le biais d’une analyse HPLC-DAD-MS,
menée à bien avant et après thioacidolyse, il a été confirmé que
les extraits de raisin prélevés sur les cépages Cabernet
Sauvignon, Carmenere, Marzemino, Merlot, Pinot Noir, Syrah et
Teroldego sont essentiellement riches en monomères et en
oligomères de petite taille (mDP < 7). Les extraits de pépin de
raisin contiennent trois monomères (catéchine, épicatéchine et
épicatéchine gallate) et des oligomères procyanidines. Les
extraits de peau de raisin contiennent quatre monomères (caté-
chine, épicatéchine, gallocatéchine et épigallocatéchine) et des
oligomères procyanidines et prodelphinidines. Les unités
supérieures et d’extension des PA sont principalement ou unique-
ment constituées d’unités épicatéchines, pour ce qui est des
pépins et de la peau respectivement. Les unités terminales des PA
de raisin sont un mélange de cinq composants, les résultats sont
les mêmes pour les monomères. Les catéchine gallate, gallocaté-
chine gallate et épigallocatéchine gallate, que l’on trouve dans
d’autres aliments et boissons dérivés des plantes et riches en fla-
vanols, ne sont pas présentes dans les extraits de raisin. Le
cépage détermine à la fois la quantité et la structure des fla-
vanols, entraînant des différences dans la composition suscepti-
bles de jouer un rôle important dans les propriétés nutritionnelles
et sensorielles des vins.
Influence of Technology on Estrogenic Activity of Red Wines
A. Zöchling1, S. Medjakovic1 and A. Jungbauer1,2
(1) University of Natural Resources and Applied Life Sciences, Department of
Biotechnology, Muthgasse 18, A-1190 Vienna, Austria.
(2) Christian Doppler Laboratory for Receptor Biotechnology, Muthgasse 18,
A-1190, Vienna, Austria.
[E-mail: alois.jungbauer@boku.ac.at]
The activation of the estrogen receptor by different isoflavones
and stilbenes is well documented. Estrogenic activity of this com-
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pounds is effected through activation of estrogen receptor a and
estrogen receptor b. Mainly trans-resveratrol has been made
responsible for the estrogenicity of red wines. Using a screening
system mimicking the transactivation of estrogen receptor a the
estrogenic potency of a selection of red wines was tested. The aim
of the study was to find out if there is a difference between red
barrique wines and red wines made without oak barrels. The
polyphenols of the wine samples were enriched by solid phase
extraction on C 18 columns. These extracts were then tested for
their estrogenic activity with a yeast transactivation assay. The
extremely permeably Saccharomyces cerevisiae strain 188 R1
transformed with an estrogen receptor a expression plasmid and
the corresponding reporter plasmid was used. Incubation of yeast
with an estrogenically active substance leads to binding of the
estrogen receptor a dimer to the estrogen response element and
thus to expression of b-galactosidase. The specific enzyme activ-
ity is equivalent to the amount of estrogenic activity. Both red
wines with and without barrique contact were able to transacti-
vate human estrogen receptor a and the arylhydrocarbon receptor
in yeast. We hypothesised that other estrogenic compounds than
resveratrol are present in this wines. A negative or positive health
impact must be discussed with care. These compounds are pre-
sent in low concentrations compared to plant extracts used as
herbal remedies.
L’activation des récepteurs aux oestrogènes par différents
isoflavones et stilbenes sont bien documentés. L’activité
oestrogène de ces composés s’effectue au travers de l’activation
des récepteurs aux oestrogène a et b. C’est principalement le
trans-resveratrol qui est tenu pour responsable de l’activité
oestrogène du vin rouge. En utilisant un système de criblage
immitant la transactivation des récepteurs aux oestrogènes a, le
potentiel d’activité oestrogène d’une selection de vins rouges a
été testé. L’objectif de ce travail était de déterminé s’il existe une
différence entre les vins rouges affinés en barrique et les vins ne
subissant pas ce traitement. Les polyphénols des extraits de vins
furent enrichi par extraction en phase solide sur colonne C18.
Ces extraits furent ensuite testés pour leur activité oestrogène en
utilisant un système de transactivation chez la levure. La souche
extrèmement poreuse 188 R1 de Saccharomyces cerevisiae trans-
formée avec un plasmide d’expression du récepteur a à l’oe-
strogène et avec le plasmide raporteur correspondant a été
utilise. L’incubation des levures avec une substance à activité
oestrogène conduit à la fixation du dimère de recepteur a à l’oe-
strogène à l’élément de réponse à l’oestrogène et de ce fait à l’ex-
pression de b-galactosidase.L’activité spécifique de l’enzyme est
proportionnelle à l’acivité oestrogène de la substance testée. Les
vins des deux origines, affinés ou non en barriques se révélèrent
capables de transactiver le récepteur a humain à l’oestrogène et
le récepteur à l’arylhydrocarbone chez la levure. Nous emmet-
tons l’hypothèse que d’autres substances oestrogènes que le
resveratrol sont présentes dans ces vin. Un impact négative ou
positif sur la santé humaine doit donner lieu à une discussion
attentive. Ces substances sont présentes à de faibles concentra-
tions en comparaison des extraits de plantes à usage.
Unravelling the Total Antioxidant Capacity of Pinotage Wines
– the Contribution of Phenolic Compounds
D. de Beer1, E. Joubert2, J. Marais2, M. Manley1
(1) Department of Food Science, Stellenbosch University, Private Bag X1,
Matieland, 7600, South Africa.
[E-mail: DBeerD@arc.agric.za]
(2) Post-Harvest and Wine Technology Division, ARC Infruitec-Nietvoorbij,
PO Box X5026, Stellenbosch, 7599, South Africa.
[E-mail: JoubertL@arc.agric.za].
Pinotage is a South African red wine cultivar with a unique phe-
nolic profile. An understanding of the contribution of individual
phenolic compounds on the total antioxidant capacity of Pinotage
wines, is important for determining guidelines for the production
of Pinotage wines with optimal total antioxidant capacity. These
aspects were the main focus of the study. The Trolox equivalent
antioxidant capacity (TEAC) of individual phenolic compounds,
namely gallic acid, caffeic acid, caftaric acid, p-coumaric acid,
(+)-catechin, (-)-epicatechin, procyanidin B1, delphinidin-3-glc,
petunidin-3-glc, cyanidin-3-glc, peonidin-3-glc, malvidin-3-glc,
quercetin-3-glc, myricetin-3-glc, quercetin-3-gal, quercetin-3-
rham, myricetin, quercetin, kaempferol and isorhamnetin, were
determined using the ABTS•+ scavenging assay. The individual
phenolic content and total antioxidant capacity (TAC) of 139
Pinotage wines were determined using HPLC and the ABTS•+
scavenging assay, respectively. The contributions of the quanti-
fied compounds were calculated from their concentrations in the
wine and TEAC values. The contribution of polymeric com-
pounds was determined by separating the monomeric and pheno-
lic compounds in three wines using ultrafiltration. Possible syn-
ergistic interactions were tested by combining individual pheno-
lic compounds to mimic the phenolic profile of three wines and
measuring the TAC of the mixture. The TEAC values of
quercetin-3-gal, isorhamnetin and peonidin-3-glc are reported
here for the first time to the best of the authors’ knowledge.
Esterification of caffeic acid with tartaric acid, i.e. caftaric acid
caused a decrease in TEAC value. Quercetin-3-rham and
quercetin-3-gal also had much lower TEAC values than quercetin
as is the case for quercetin-3-glc. Peonidin-3-glc has a TEAC
value higher than malvidin-3-glc due to one less electron-with-
drawing methoxy group, but a TEAC value lower than delphini-
din-3-glc and petunidin-3-glc due to less hydroxyl groups. Of the
compounds found in Pinotage wines, p-coumaric acid and pro-
cyanidin B1 had the lowest and highest TEAC values, respective-
ly. The highest contributions to the TAC of Pinotage wines were
either compounds present in large concentrations such as caftaric
acid and malvidin-3-glc, or compounds with high TEAC values
such as gallic acid and procyanidin B1. The total calculated TAC
was, however, only between 11 and 24% of the measured TAC.
The contribution of polymeric phenolic compounds and other
unknown large compounds isolated from three wines using ultra-
filtration were 54% indicating that unknown small compounds
also contribute to the TAC of Pinotage wines. Some synergism
was detected in mixtures mimicking the concentrations of 12 phe-
nolic compounds in three wines. The total antioxidant capacity of
Pinotage wines is influenced by several factors, namely individ-
ual phenolic compounds, polymeric compounds, unknown com-
pounds and possible synergistic interactions between compounds.
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Our Operating Environment: Snapshot of Countries’ Public
Health Policies and Guidelines on Alcohol and Hence Wine
Consumption
C.S. Stockley (Keynote Speaker)
The Australian Wine Research Institute (AWRI)
[creina.stockley@awri.com.au]
Worldwide, approximately 2 billion people consume alcoholic bev-
erages such as wine, beer and spirits. The mean adult global per
capita consumption of ‘pure’ alcohol is 5.1 L, which is divided
approximately equally between beer, spirits and wine. The pharma-
cological textbooks list alcohol as a drug that has dose-dependent
effects. When the dose is low to moderate, the effect can be consid-
ered as a benefit to health but when the dose is high or abusive, the
effect is considered as a harm to health. Of those 2 billion people
that consume alcoholic beverages worldwide, approximately 76.3
million or 3.8% have alcohol-related problems due to alcohol abuse,
and 1.8 million or 0.09% will die from alcohol-related harms.
Clearly public health policies on alcohol consumption are necessary
to address the economic, health and social impacts of alcohol-relat-
ed harms. Coronary heart disease, however, is the leading cause of
death in developed countries and its incidence is increasing in devel-
oping countries. While high alcohol consumption increases the inci-
dence of hypertension, cardiac arrhythmias, congestive heart failure
and haemorrhagic stroke, low to moderate alcohol consumption
actually decreases the risk of coronary heart disease. Moderation is
consistently defined as 20–40g ethanol per day. The beneficial
health effects of alcohol consumption thus provide significant chal-
lenges for alcohol policy but these data are gradually being accept-
ed and considered when countries are developing and subsequently
reviewing their public health policies on alcohol consumption. This
paper focuses on the evolution of public health policy and associat-
ed guidelines in those countries which have based them on recent
review of the medical and scientific literature. It is suggested that a
legitimate role for researchers in policy development is to under-
stand and provide detailed knowledge of the biological mechanisms
of alcohol consumption in order to provide a context for the policies,
and to aid in educating the consumer.
Alcohol and Emotions: Friend or Foe?
W. Pienaar
Department of Psychiatry, Faculty of Health Sciences, University of Stellenbosch,
7600 Stellenbosch, South Africa
The first draught serveth for health, the second for pleasure, the third
for shame, the fourth for madness” Sir Walter Raleigh 1552-1618.
Man has known for many years that alcohol has a stabilizing effect
on the mood. It is also true that moderate drinkers tend to have bet-
ter health and live longer than those who are either abstainers or
heavy drinkers. The positive effects of alcohol on the mood of some
people, re-inforces the regular use of the substance in many. In most
people this would lead to a life-long happy relationship. During the
presentation the mood stabilizing effects of alcohol will be high-
lighted. Healthy drinking patterns and the causal factors for the
development of alcohol dependency will be explored. “Wine makes
daily living easier, less hurried with fewer tensions and more toler-
able” Benjamin Franklin.
Industry Action through the ARA in Addressing Alcohol
Abuse
C. Makan
Industry Association for Responsible Alcohol Use (ARA) and Foundation for
Alcohol Related Research (FARR), P O Box 112, Bergvliet 7864 & P O Box
30324, Tokai 7966
[Email: cmakan@iafrica.com]
A social aspects organisation (SAO) like the ARA inevitably faces
the challenge in having to decide where to direct its efforts in
addressing the consequences of alcohol abuse. Areas of preven-
tion, treatment and rehabilitation make demands on its resources.
The ARA is an example of an SAO which has made a conscious
decision to focus on prevention. This paper explains why this area
was chosen for its strategic focus and how it has succeeded in
doing so in partnership with other stakeholders. A brief outline of
programmes in the areas of education, industry self-regulation,
research and alcohol abuse prevention is presented.
Self Reported Surveys of Alcohol Consumption – Metho-
dologies to Improve Reliability of the Data from Surveys of
the General Population of Alcohol Consumers
A.L. Spawton, L.S. Lockshin
Wine Marketing Group, School of Marketing, University of South Australia, GPO
Box 2471, Adelaide South Australia 5001, Australia
[E-mail: tony.spawton@unisa.edu.au]
It is a general opinion that survey data on alcohol consumption is
generally an underestimate of actual alcohol consumption behav-
iour. The reasons usually relate to a consumer reticence to admit
real consumption levels due to forgetfulness, or that they are
threatened by a perceived societal prejudice towards alcohol con-
sumption generally. In order to overcome this expected consumer
propensity to underestimation, there is a growing literature sug-
gesting that utilising specific methodologies of questionnaire
design, sample design, timing of the research contact and the
method of questionnaire administration, when combined in a
study of the general population, can elicit quantity - frequency
consumption data that more closely relate to actual consumption
behaviours. This paper will first outline a review of the literature
where differing methodologies of quantity - frequency measure-
ments are tested and validated. The paper will then demonstrate
how these various methodologies can be effectively combined in a
national study of Australian alcohol consumption behaviours (n =
1005). The objectives of the Australian study were first to develop
and test a set of measurement scales to elicit consumer attitudes
towards alcohol and social-based control measures, and at the
same time to measure quantity – frequency consumption behav-
iours. The overall aim was to compare these consumption levels
with consumers’ attitudes to alcohol and social control measures
in order to understand the relationship between the two. The out-
comes of the research are designed to provide policy makers with
more effective guidelines when encouraging a culture of moderate
consumption of alcohol generally. The methodology techniques to
be discussed will be the use of focus groups to understand the
scope of the elements of alcohol consumption behaviour and how
they were understood by the consumer. Each question in the final
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measuring instrument (questionnaire) was tested during the period
and before the major field work commenced. The survey method
used was a telephone interview (25 minutes duration) with spe-
cially trained interviewers used to conduct the study. The times
when telephone contacts were made were carefully selected to
best reflect the expected behaviours of the randomly targeted
respondents and their expected propensity to be interviewed. The
conclusions drawn will provide guidance to future researchers in
the development of the measuring instrument (questionnaire) by
discussing the structure and composition of the focus groups, the
analysis of the focus group outcomes as a mechanism to develop
the individual questions to be included in the final questionnaire.
The questionnaire was constructed in such a way that consumption
ranges were able to capture heavy, light and occasional users in the
same survey. Similarly the attitudinal questions were structured to
measure the level of attitudes (1 – 7 Likert Scales) so that direct
relationships between consumption and attitude could be made.
The results of the study show that demographic factors have more
influence on attitudes than the norms of consumption (heavy,
medium, light) on moderate behaviours. 
Amount and Type of Alcohol and Morbidity and Mortality –
Results from Epidemiological Studies
M. Grønbæk (Keynote Speaker)
Centre for Alcohol Research, National Institute of Public Health, Øster Farimagsgade
5, 2.r, 1399 København K, Denmark
[E-mail: mg@niph.dk]
The association between alcohol intake and cardiovascular disease
has received quite some attention the last decade. Far most of the
studies conclude that moderate drinkers of alcohol have a
decreased risk of developing cardiovascular disease compared to
those who do not drink alcohol. While there is an increasing body
of evidence that alcohol (ethanol) itself has cardioprotective prop-
erties, the question whether there are different risks and benefits
associated with the different types of alcoholic beverages; beer,
wine and spirits, is still unresolved. However, during the last years
both epidemiological and experimental studies have brought sup-
port to the hypothesis that substances in wine have cardio- as well
as cancer-protective effects. Both case-control and cohort studies
have consistently shown that light to moderate drinkers are at
lower risk of cardiovascular disease and death than non-drinkers.
Most agree that this declining risk curve can be interpreted as a
causal relation, although the strength of the apparently protective
effect is still disputed. However, many studies report a decline in
risk of cardiovascular disease in the range of twenty five to thirty
percent. Several plausible mechanisms for the apparently cardio-
protective effect of a light to moderate intake of alcohol have been
suggested. Subjects who drink alcohol have higher serum-levels of
high density lipoprotein and lower of low density lipoprotein than
abstainers. Thus, high density lipoprotein has been suggested to be
a mediator of 40-60% of the effect of alcohol on ischemic heart
disease. Also, alcohol has a beneficial effect on platelet aggrega-
tion, and thrombin level in blood is higher among drinkers than
among non-drinkers. Recently, the largest of the prospective stud-
ies have shown that the effect of alcohol and cardiovascular dis-
ease may be modified by age and gender. Hence, two large
American studies have shown that the apparent cardioprotective
effect seems stronger among the elderly. Therefore, while the car-
dioprotective effect of a light to moderate alcohol intake is quite
evident based on a large number of epidemiological studies, there
are several factors which may influence the strength of the effect.
A number of recent cohort studies have addressed the question
whether there are differences in the effect of drinking wine, beer
and spirits. Most of those having been able to address the question
in populations with a variation in intake of all three types of bev-
erages have found wine drinkers to be at lower risk of all cause
mortality and in some instances also of mortality from cardiovas-
cular disease. A larger number of studies of the effect of alcohol
on incidence of cardiovascular disease have superficially
addressed the question of different effects of the different types of
beverages. Substances in wine have been shown to have the
platelet aggregation inhibiting effect also found to pertain to
ethanol. Further, an inhibiting effect on low density lipoprotein
oxidation of unknown factors in wine was shown. Also other
mechanisms related to not specified factors in wine, have been
suggested to play a role in the prevention of cardiovascular dis-
ease. Apart from the effect on platelet and low density lipoprotein
oxidation, a vasodilating effect has been proposed, perhaps due to
an effect of wine on the endothelium. The suggestions from the
experimental studies have only been sparsely reproduced in popu-
lation studies. Thus, one of the first studies on flavonoid intake in
humans, found a lower risk of coronary heart disease among sub-
jects who had a high dietary intake of flavonoids, while data from
the Nurses Health Study did not support the findings. Further, sev-
eral other antioxidant effects which may inhibit carcinogenesis but
also may have an effect on cardiovascular disease have been pro-
posed. Several of these antioxidants are present in both fruits and
vegetables, as well as in wine. When reviewing the different epi-
demiological papers on type of beverage and cardiovascular dis-
ease, the question still remains whether it is the drink or the
drinker? As mentioned above, several biological mechanisms from
substances present in wine but in beer and spirits may explain the
epidemiolocal findings. However, recently a few studies have
shown that other factors, differently distributed among wine
drinkers and non-wine drinkers may confound the above men-
tioned relations. A high intake of fruits, vegetables and fish and a
low intake of saturated fat has been suggested to reduce the risk of
cardiovascular disease. The so-called Mediterranean diet which
includes fruits and vegetables has in six out of ten cohort studies
been found to have a weak protective effect on cardiovascular dis-
ease. In studies from US and Denmark preference of wine was
associated with a high intake of fruit, vegetable, fish, salad and a
high frequent use of olive oil for cooking compared with prefer-
ence of beer and spirits in both men and women. However, the
confounding effect of dietary factors should be very strong to
explain the above mentioned findings. Further, recent studies from
Italy and France suggest that diet is not a strong confounder in
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these countries, where wine has also been found to have addition-
al effect compared to beer and spirits. Self-reported subjective
health has in several studies shown to be a strong predictor of car-
diovascular disease and all-cause mortality. In studies from both
Helsinki and Copenhagen it was shown that beer drinkers were
more likely to have suboptimal health than those who preferred
wine. Another factor which may be of importance drinking pat-
tern. A recent very large Danish study have shown that binge
drinkers have a higher mortality from all causes than steady
drinkers. With regard to coronary heart disease, a study from
Harvaard University shows that those who were steady drinkers
had an apparently beneficial effect of drinking light to moderate-
ly. Hence, if wine drinkers were steady drinkers and beer drinkers
more likely binge drinkers, this may itself explain the above men-
tioned differences. However, a recent study from Denmark
showed that this does not seem to, since wine drinkers were more
likely to binge than beer drinkers. 
In conclusion most epidemiological studies support the clinical
and the experimental suggestions of an effect of wine in addition
to a light to moderate alcohol intake on cardiovascular disease,
and some newer studies show that carcinogenesis may be
impaired by wine intake, although the differences between the
effects of the different types of alcohol to a large extend may be
due to confounding.
THEME: Cardiology / Endocrinology
SESSION IV: Cardiovascular Implications of Alcohol / Wine Consumption
Alcohol and Cardiovascular Diseases: A Historical Review
and 2005 Update
L. Klatsky (Keynote Speaker)
Kaiser Permanente Medical Care Program, Oakland, California, USA
Study of the history of a subject seldom fails to provide insights
about current knowledge. One important result is recognition of
past mistakes, creating the potential for avoiding their repetition.
Attempts to generalize and simplify about alcohol and cardiovas-
cular (CV) diseases have slowed progress. Disparities in relations
of alcohol drinking to various CV conditions are now clear. A
basic disparity between the effects of lighter and heavier drinking
always cuts through alcohol-health relations. In this brief
overview, the following will be considered: cardiomyopathy,
arsenic and cobalt beer drinkers’ disease, cardiovascular beri-beri,
systemic hypertension (HTN), cardiac arrhythmias, cerebrovas-
cular disease, atherosclerotic coronary heart disease (CHD), and
heart failure.
Monocyte Function in Hypercholesterolemic Patients –
Influence of GM-CSF
S.H Schirmer2,3, C. Page1, R. Meldau1, D. Marais4, I.R Busch-
mann5, J.A. Moolman1
(1) University of Stellenbosch, Tygerberg Hospital, Cape Town, South Africa
(2) University Hospital Freiburg, Germany
(3) Academic Medical Center, Amsterdam, Netherlands
(4) University of Cape Town, Groote Schuur Hospital, Cape Town, South Africa
(5) Charité Berlin, Germany
Monocytes are known to play an essential role in atherosclerosis
but also to orchestrate collateral artery growth (arteriogenesis). In
both settings, monocyte adhesion to the vascular endothelium,
their transmigration into perivascular tissue and secretion of
growth factors and cytokines has been shown. Granulocyte-
macrophage colony-stimulating factor (GM-CSF) is known to
strongly stimulate arteriogenesis, modifying monocyte function
and prolonging their life span. While effects of circulating cho-
lesterol on atherosclerosis are well known, the effects on arterio-
genesis are yet unresolved. In this study we analyzed the effects
of GM-CSF on monocyte surface marker expression and gene
programming. Monocytes were isolated using magnetic beads
from peripheral blood mononuclear cells of patients with familial
hypercholesterolemia and of age, gender and race matched con-
trols. Surface marker expression was analyzed by flow cytometry
after staining with fluorescent monoclonal antibodies for CD11b,
CD14 and CD44. Also mRNA was isolated from these cells and
gene expression was investigated using real-time PCR. Surface
protein expression of the adhesion molecule CD11b was signifi-
cantly higher in patients with hypercholesterolemia at baseline.
48h of culture resulted in equal cell surface expression of this
marker in controls as well as patients. GM-CSF stimulation
caused a marked increase in monocytes from controls, compared
to monocytes form patients. Gene analysis of the surface markers
supported the protein data, presenting a significantly lessened
decrease of CD11b gene expression after culture with GM-CSF
in both patients and controls. The expression of genes known to
play an important role in arteriogenesis (MMP-12, CISH, MCP-
1) in response to GM-CSF was increased in controls compared to
hypercholesterolemic patients. Monocytes from hypercholes-
terolemic patients respond less vigorously to the arteriogenic
stimulus GM-CSF with regard to the expression of the cell-adhe-
sion molecule CD11b, as well as activation of genes associated
with arteriogenesis. This may indicate that cholesterol suppresses
the ability of monocytes to activate arteriogenesis.
Red Wine and Heart: A Journey from Grape to Resveratrol
D.K. Das
Cardiovascular Research Center, University of Connecticut School of Medicine,
Farmington, CT 06030-1110, U.S.A
[Email: DDAS@NEURON.UCHC.EDU]
The consumption of wine, particularly red wine, imparts benefi-
cial effects in the prevention of coronary heart disease. Our study
determined that mild to moderate wine consumption (equivalent
to one to two glasses of wine/day) rendered the heart resistant to
ischemia and heart failure. This gave rise to what is now popular-
ly termed as the French Paradox. A recent study determined that
regular consumption of grapes also render the myocardium resis-
tant to ischemic heart disease. In this study, the rats were given
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(orally) Standardized Grape Extract (SGE) (obtained from
California Table grape Commission) for a period of one month.
After 30 days, the rats were sacrificed, hearts excised and made
ischemic for 30 min followed by 2 hrs of reperfusion. At 100
mg/kg and at 200 mg/kg, grapes provided significant cardiopro-
tection as evidenced by improved post-ischemic ventricular
recovery and reduced amount of myocardial infarction. SGE
reduced the malonaldehyde content of the heart indicating reduc-
tion of oxidative stress during ischemia and reperfusion. The car-
dioprotective effects of red wine have been attributed to several
polyphenolic antioxidants including resveratrol and proanthocyani-
dins that are present in the wine and the grapes. Our study deter-
mined that these polyphenolic antioxidants provide cardioprotec-
tion by their ability to function as in vivo antioxidants. These phe-
nols as well as red wine triggered a signal transduction cascade ini-
tiated by the activation of adenosine A1 and A3 receptors thereby
activating MAP kinase signaling leading to a reduction of pro-
apoptotic transcription factors and genes such as JNK-1 and c-Jun
and inducing redox-sensitive transcription factor NFkB thereby
potentiating ischemia-mediated anti-death signal. This results in
the reduction of cardiomyocyte apoptosis. Resveratrol mediated
anti-apoptotic signal appears to be potentiated by an upregulation
of nitric oxide leading to the initiation of an angiogenic signal trig-
gered by an induction of vascular endothelial growth factor. The
results, thus, indicate that not only do the red wine and grapes pro-
vide cardioprotection through their antioxidative properties, but
also they have ability to trigger a survival signal through the
polyphenolic antioxidants, especially resveratrol.
The Relation of Alcohol Consumption to Calcified
Atherosclerotic Plaque in the Coronary Arteries and Aorta
R.C. Ellison, R.C.1, Y. Zhang, Y.1, P.N. Hopkins2, S. Knox3,
L. Djoussé1, J.J. Carr4
(1) Section of Preventive Medicine and Epidemiology, Boston University School
of Medicine,715 Albany Street, Boston, MA 02118, USA.;
(2) Division of Cardiology, Cardiovascular Genetics, University of Utah, Salt
Lake City, UT
(3) Division of Epidemiology, Statistics and Prevention Research, The National
Children’s Study, Bethesda, MD
(4) Departments of Radiology and Public Health Sciences, Wake Forest Uni-
versity School of Medicine, Winston-Salem, NC.
[E-mail: ellison@bu.edu]
There have been conflicting results on the relation of alcohol con-
sumption to the presence of calcified atherosclerotic plaque in the
coronary arteries (CAC), which is increasingly being used as a
non-invasive index of atherosclerosis. Previous studies have sug-
gested that wine and/or alcohol reduce, increase, or have no effect
on CAC. We evaluated the relation of alcohol intake to the pres-
ence of CAC and calcified plaque in the aorta among 3,166 white
and African-American subjects from the National Heart, Lung,
and Blood Institute Family Heart Study who underwent cardiac
CT scans. With adjustments for age, race, study center, BMI,
hyperglycemia/diabetes, hypertension, and smoking, odds ratios
(and 95% CI) for CAC scores > 100 for non-drinkers and con-
sumers of 1-3, 4-7, 8-14, and > 14 drinks per week were 1.0, 0.8
(0.4, 1.3), 1.1 (0.6, 1.9), 0.9 (0.5, 1.5), and 1.5 (0.9, 2.5) for men
and 1.0, 0.9 (0.5, 1.6), 1.3 (0.8, 2.3), 1.3 (0.7, 2.2), and 2.1 (0.8,
5.9) for women. Sensitivity analyses with other cut-points for cal-
cified plaque gave similar results. Analyses of alcohol and aortic
calcification showed similar, non-significant associations. We
conclude that despite its beneficial effects on coronary artery dis-
ease risk, moderate alcohol consumption does not relate signifi-
cantly to calcified atherosclerotic plaque in the coronary arteries
or in the aorta. These findings suggest that the protective effects
of moderate alcohol consumption against cardiovascular events
may occur through different mechanisms than those associated
with the development of calcified atherosclerotic plaque.
Moderate Wine Drinkers Have Lower Hypertension Related
Mortality: A Prospective Cohort Study in 36 000 French Men
D. Lanzmann-Petithory1, S. C. Renaud1, R. Guéguen2,
J.M. Orgogozo3, O. Henry1
Centre Hospitalier Emile Roux, Assistance Publique des Hôpitaux de Paris. 
1, avenue de Verdun, 94456 Limeil-Brévannes Cedex France
Centre de Médecine Préventive, 54500 Vandoeuvre-Les-Nancy, France. 
University Bordeaux 2, 146, rue Léo-Saignat, 33076 Bordeaux Cedex, France.
[E-mail : dominique.lanzmann@erx.ap-hop-paris.fr]
For a given blood pressure, risk of death from coronary heart dis-
ease in Northern Europe and USA is much higher than in
Mediterranean Countries. In this prospective cohort study, we
tested the hypothesis that regular wine drinking might reduce
hypertension-related risk of death. We used data on 36, 583 con-
secutive healthy middle-aged men with a normal electrocardio-
gram, not taking drugs for cardiovascular risk factors. These sub-
jects underwent comprehensive health appraisal in a Center for
Preventive Medicine between January 1st, 1978 and December
31st, 1985. Mortality from all-causes and specific causes during
a 13 to 21 years follow-up was recorded. In a Cox model adjust-
ed for six confounding variables, moderate wine drinkers (<60 g
alcohol/day and no beer), compared with abstainers, have a lower
risk of death from all-causes by 23% with SBP of 158 mmHg
[RR 0.77 (CI 0.62-0.96, p<0.02)], 27% with SBP of 139 mmHg
[RR 0.73 (CI 0.58-0.91, p<0.01)] and 37% with a SBP of 116
mmHg [RR 0.63 (CI 0.51-0.78, p<0.001)]. Even for the highest
quartile of blood pressure, moderate wine drinkers and only them,
are protected from all causes mortality. No significant reduction
in all causes mortality in relation to SBP was observed in other
drinkers (≥60g alcohol/day or consuming beer and wine), partic-
ularly in the highest quartile of blood pressure, where the non
moderate drinkers (≥60g alcohol/day) have a higher risk [RR 1.26
(CI 1.01-1.57, p<0.04)] for the wine and no beer drinkers and
[RR 1.34 (CI 1.07-1.67, p<0.01)] for the beer drinkers. A moder-
ate intake of wine is associated with a lower risk of hypertension
related mortality from all-causes.
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Endothelial Activation, Vascular Inflammation and Coronary
Artery Disease
Raffaele De Caterina, MD, PhD
Institute of Cardiology, University Cardiology Division, and Center of Excellence
on Aging, “G. d’Annunzio” University – Chieti, Italy, and #Laboratory for
Thrombosis and Vascular Research, CNR Institute of Clinical Physiology, Pisa, Italy
[Email: rdecater@unich.it]
Current evidence suggests that most significant risk factors for
heart disease have been identified. Indeed, the majority of new
cases of acute myocardial infarctions can today be predicted by
the presence and the level of nine risk (or cardioprotective) fac-
tors that can easily be assessed and, most importantly, modified.
These risk factors are the same in almost every geographic region
and in every racial/ethnic group worldwide, and are consistent in
men and women. Eight out of these nine risk factors are influ-
enced by diet, and most act promoting atherogenesis, which is the
most important background condition for cardiovascular disease.
Dietary interventions mostly impact on atherogenesis by modu-
lating pro-inflammatory processes at the cellular level that initi-
ate and perpetuate endothelial dysfunction, plaque formation and,
eventually, plaque rupture. As an example, there is now enough
evidence, both epidemiological and clinical, for the beneficial
effects of omega-3 fatty acids, monounsaturated fatty acids or
Mediterranean diet antioxidant polyphenols.
The Influence of a Mediterranean Diet With and Without
Red Wine on the Haemostatic and Inflammatory Parameters
of Subjects With the Metabolic Syndrome
E. Mansvelt1, D. Van Velden1, E. Fourie2, D. Blackhurst3, T. Kotze1,
H. Stofberg2, S. Van der Merwe4
University of Stellenbosch1, NHLS Tygerberg2, University of Cape Town3,
PAWC4
[E-mail: epgm@sun.ac.za]
Some antithrombotic effects of the Mediterranean diet comple-
mented by red wine could be proved on normal subjects. In a later
study, addition of red wine did not add to the benefits of the
Mediterranean diet except for prolongation of the bleeding times.
Platelets play an important role in thrombosis and in myocardial
infarction and the effect of wine consumption on platelet actvity has
been reviewed by previous researchers. Procoagulants and antico-
agulants also participate in thrombogenesis: FVII (affected by
dietary triglycerides), FVIII and fibrinogen (both affected by
inflammatory responses) and von Willebrand’s factor (vWF) that is
also used as a marker of endothelial function. CRP and fibrinogen
are markers of vascular inflammation in atherogenesis and in the
metabolic syndrome. Finally the fibrinolytic pathway’s efficiency to
resolve a formed thrombus, plays an important role via tPA and PAI-
1 activities. Variable results in these fibrinolytic markers in relation
to wine and/or alcohol consumption were described before. This
study examined whether a Mediterranean-like diet supplemented
with red wine, complemented with mild exercise had an acute
impact on patients diagnosed with the metabolic syndrome. In this
study, 12 non-smoking patients between the ages 32 to 60 years
with diagnostic criteria of the metabolic syndrome on minimal med-
ication, consumed a Mediterranean-like diet for 4 weeks respective-
ly without and with red wine. During the experimental periods the
subjects increased their intake of vegetables, cereals, fruit, mono-
unsaturated fatty acids and fish at the expense of red meats and dairy
products. Patients were motivated to include 20 – 30 minutes of
mild exercise (walking) into their daily routine. Dietary control was
through 4 times 3-day dietary record during the study period. The
amount of red wine added to the diet was 250 ml (26 grams of alco-
hol) per day for male and 180 ml (19 grams) per day for female par-
ticipants. A genetic profile for cardiovascular risk factors was per-
formed on all the subjects to identify specific familial disorders and
as selection criteria to confirm the clinical diagnosis. Risk reduction
assessment linked to nutrition and lifestyle that target the interaction
between genes and the environment was done for each participant.
Biochemical and haemostatic assessments were determined on all
participants to compare the effect of their habitual and newly
acquired lifestyles and diet with and without wine. Fasting blood
samples were taken at base line, after 4 weeks of diet and after
another 4 weeks of diet plus moderate red wine consumption.
Weight, abdominal circumference and blood pressure were mea-
sured at each visit. Contrary to the literature findings, wine demon-
strated no additional anti-atherogenic or antihaemostatic effects in
our subjects in this study. Our study aimed at the longterm benefi-
cial effects of moderate wine consumption on biological parame-
ters. It could be that the effect of diet and wine is not clearly demon-
stratable in such a short term intervention period. It is also probable
that the diet showed more favourable effects on health parameters as
the anti-oxidant capacity of the plasma because the diet was contin-
ued for double the period of time for that of wine intake. However,
wine was added last in the intervention and the beneficial anti-oxi-
dant effect of the diet alone was probably partially reversed by the
addition of alcohol. This would be further resolved when the geno-
types like ApoE4 of our study subjects become known.
Alcohol, Wine, Platelet Function and Haemostasis
J-C. Ruf
Wine, Nutrition and Health Unit of The International Organisation of Vine and
Wine, Intergovernment Organisation, 18 Rue Aguesseau – F-75008 Paris, France
[jruf@oiv.int]
Red wine is rich in the complex polyphenols and these com-
pounds have attracted attention as potential cardiac-protective
compounds. The present review summarizes the literature on
wine polyphenols and the evidence for a protective effect on
blood platelets. In fact, while the mechanisms underlying the
effects of alcohol on cardiovascular disease have been limited to
lipid metabolism and the haemostatic system, those related to
wine consumption have also been extended to specific anti-
inflammatory, antioxidant and nitric oxide related vaso-relaxant
properties of its. In addition, it has become evident that blood
platelets contribute to the rate of development of atherosclerosis
and CHD through several mechanisms. Several studies carried
out on humans and animals have shown that wine phenolics could
exert their effects by reducing prostanoid synthesis from arachi-
donate. In addition, it has been suggested that wine phenolics
could reduce platelet activity mediated by nitric oxide. Moreover,
wine phenolics increase vitamin E levels while decreasing the
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oxidation of platelets submitted to oxidative stress. However, a
rebound phenomenon of hyperaggregability is observed after an
acute alcohol consumption which is not observed with wine con-
sumption. We shall summarize here the experimental studies with
wine or wine-derived products aimed at finding biological ex-
planations for the supposed effects on blood platelets of wine
consumption.
Wine Dilates the Brachial Artery but Does Not Increase Flow
Mediated Dilatation Over Two Hours
D.M. Blackhurst, J.E. Freislich, A.D. Marais
Lipidology Division, University of Cape Town Health Sciences Faculty, Anzio
Road, Observatory 7925, South Africa
[E-mail: dblackhu@capeheart.uct.ac.za]
There is epidemiological evidence for possible cardiovascular ben-
efits from consumption of alcoholic beverages, but corroboration by
functional and outcome studies is still outstanding. We performed
non-invasive functional tests on the brachial arteries of healthy vol-
unteers before and for two hours after consuming red wine, calcu-
lated to deliver 0.35g alcohol/kg body mass. An Acuson 128 ultra-
sound machine (7.5MHz transducer) generated images of the
brachial artery. Brachial artery dimensions were taken at baseline,
30, 60 and 120 min. Similarly, FMD was assessed after 5 min of
forearm occlusion by a sphygmomanometer cuff inflated to 50mm
Hg above systolic blood pressure. Putative minimum and maximum
lumen diameters were determined after ice immersion and sublin-
gual trinitroglycerine (TNG) at baseline and 60 min after wine con-
sumption. 16 subjects had a mean ± SD resting brachial artery diam-
eter of 3.84 ± 0.61mm that significantly increased on wine to 4.44
± 0.58 at 30min, 4.39 ± 0.62 at 60 min and 4.49 ± 0.62 at 120 min
(P < 0.0001). The calculated blood flow rates during the study did
not differ significantly over the measured intervals. The baseline
mean diameter with TNG was not significantly different from the
dilation with wine. The vasoconstrictor response varied widely, with
a –2.6 ± 2.9% change from baseline diameter. There was apprecia-
ble variation of the diameter relative to the range found with the
individual ice and TNG. The calculated FMD (% changes) for the
study were 10.8 ± 4.6, 6.1 ± 2.9, 5.6 ± 4.2 and 7.5 ± 2.7 indicating
statistically significant effects of wine (P < 0.0001). We conclude
that red wine consumption leads to arterial dilation even under vaso-
constrictory conditions. FMD is significantly reduced within 30 min
of consumption and is significantly depressed for at least 2 hours.
Since red wine is a complex beverage, further studies need to be
done to discriminate the effects of alcohol and phenolic compounds
on vascular function. The potential beneficial effects of wine may
relate to different doses or other mechanisms than FMD.
SESSION VI: Wine and Lipid Metabolism
From the Ancient Wisdom of Greek and Roman Civilization
the Recommendations for a Healthy Diet, Where Post-pran-
dial Oxidative Stress and Cellular Stress Response is Pre-
vented
F. Ursini (Keynote Speaker)
Department of Biological Chemistry, University of Padova, Viale G. Colombo 3,
35121 Padova, Italy
[E-mail: fulvio.ursini@unipd.it]
The “modern” notion of Mediterranean diet has been introduced
by Ancel Keys as a nutritional approach to prevent chronic degen-
erative diseases, mainly atherosclerosis. The major features of
Mediterranean diet are a high intake of vegetables, legumes,
fruits, cereals, the use of olive oil, a low intake of meat and final-
ly a regular intake of wine at meals. The antithetic counterpart is
the typical diet of Northern Europe and Northern America, where
meat consumption is higher, the fats are either animal or hydro-
genated, the intake of fruit and vegetables is low and spirits and
beer substitute for wine. Remarkably, the same antinomy among
nutritional habits is observed when eating pattern of ancient
Greeks and Romans is compared with that of emerging Northern
barbarian populations. The notion of producing foods by cultivat-
ing fields had to compete with the notion of catching what is
available in the forest. Hunting and eating large amounts of meat
was the pattern of warriors that eventually conquered the Roman
Empire. Thus, we have now to “rediscover”, as the legacy of an
ancient wisdom, the Mediterranean diet. Searching for the mole-
cular mechanisms of health benefits of this diet, already unques-
tionably identified in epidemiological studies, it could be conve-
nient introducing the recent concept of “post-prandial oxidative
stress”. Several foods containing partially oxidized fat and cata-
lysts of lipid peroxidation (i.e. meat, mainly bovine) increase the
oxidation and oxidability of lipids in plasma lipoproteins, eventu-
ally leading to a misfolding of apo B. An altered oxidative bal-
ance in plasma leads to endothelial dysfunction (an early hall-
mark of atherogenesis) and, in general, to a cellular response to
stress. This stress response is nowadays seen as the biological
mechanism of an alteration of homeostasis, eventually leading to
chronic diseases. Fruit, vegetables, olive oil and wine taken with
foods bring all the elements to counteract such a response. The
post-prandial increase of lipid hydroperoxides is minimized and
the cellular stress response is turned down. Such a view of a
healthy effect of a diet as a whole could also eventually explain
why nutritional supplements, usually taken while fasting, are only
minimally active in disease prevention.
Dyslipoproteinaemia in South Africa
A D Marais
Internal Medicine, Groote Schuur Hospital & University of Cape Town
The link between lifestyle and plasma cholesterol and atheroscle-
rotic vascular disease is clearly demonstrated by studies within and
between populations. Dyslipoproteinaemias impart much higher
risk of cardiovascular disease. Genetic dyslipidaemias have been
well-characterised over the past 25 years. Having initially been
described from the clinical evaluation, plasma lipoprotein patterns
allowed insight into dyslipidaemias according to defects in proteins
functioning as receptors or enzymes and ultimately have been clar-
ified at the genetic level. Genetic dyslipidaemias are enriched in the
South African population as a result of founder effects in several of
its ethnic groups. Familial hypercholesterolaemia (FH) is the best
studied of these disorders. It is recognised by premature heart dis-
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ease, tendon xanthomata and low density (LDL) cholesterol hyper-
cholesterolaemia (>5mmol /L). Mutations in the LDL receptor have
been identified in the Afrikaner, Jewish, Indian, Black and mixed
ancestry population. Cardiovascular disease in these subjects is
influenced by lifestyle as well as many other risk factors. Although
statins have made a dramatic impact on the control of dyslipidaemia
in FH, adopting a healthy lifestyle remains important.
Nutritional Genetics: Development and Application of an
Individualised Approach for Cardiovascular Disease Risk
Reduction
M.J. Kotze
Genecare Molecular Genetics (Pty) Ltd, Christiaan Barnard Memorial Hospital,
Cape Town. [mjk@genecare.co.za]
A rapid DNA test has been developed which screens for familial
hypercholesterolaemia (FH) and other genetic risk factors that can
be triggered into cardiovascular disease (CVD) by lifestyle risk fac-
tors, if left untreated. This multi-gene CVD test consists of four
components – dyslipidaemia, folate metabolism, coagulation and
iron overload – that are evaluated in the context of family and med-
ical history (e.g. hypertension, obesity, diabetes), biochemical para-
meters and relevant environmental risk factors. Testing for specific
genetic alterations involved in lipoprotein and lipid metabolism are
particularly useful to identify individuals who may not benefit from
certain dietary measures to lower CVD risk, such as moderate alco-
hol drinking. Convincing evidence has been provided that the com-
mon E4 allele of the apolipoprotein E gene, which occurs in approx-
imately 30% of the general South African population, modulates the
effect of alcohol intake on plasma lipids and consequently CVD
risk. Apart from alcohol, a diet high in saturated fat and cholesterol
as well as smoking should be avoided because the risk imposed by
these factors is significantly increased in the presence of the Apo E4
allele. By combining genetic testing for both monogenic and multi-
factorial conditions, it has become possible to distinguish between
patients with FH requiring life-long drug treatment and those at
increased CVD risk as a consequence of other factors that can be
treated effectively by dietary and lifestyle intervention.
Modification of Cardiac and Stroke Risk Factors through the
Implementation of a Lifestyle Intervention Programme:
A Gene Based Phased Approach
H. Avenant
Blueprint Health SA, Suite 2F, Arun Place, Sir Lowry’s Pass Drive, Somerset West
Current medical infrastructure has been inaccessible to cater for
preventative care. This caused individuals to look for advice else-
where. This situation left the medical fraternity on the sideline in
terms of creating and using opportunities to contribute to a health-
ier population in general. The morbidity of cardiovascular disease
and strokes was recently reiterated by data provide by the World
Health Organization, when they were respectively listed first and
forth on the list of the 10 most prevalent diseases causing disabil-
ity. The occurrence of these diseases depends largely on interac-
tion between the environment and the genetic predisposition of an
individual. By modifying the environment, it is possible to modi-
fy or minimise the expression of many deleterious gene mutations.
Knowledge of our genetic heritage now provides a sound basis for
proactive long term planning to invest in one’s health, the most
valuable asset of any person. Healthcare practitioners will have to
emphasize the fact that preventive care pays, both in terms of cost
and quality of life. Consequently, serious consideration is called
for to pursue avenues by which some advances can be made in bet-
tering the cardiovascular health of individuals. An integrated
lifestyle intervention programme was developed to provide practi-
cal strategies to support the numerous studies that document cost
effective, improved outcomes of lifestyle intervention over sec-
ondary intervention techniques. An important aspect of this pro-
gram is to foster the realization that this health principle should be
applied in families across the board. Expanding awareness to the
community at large as to what a healthy lifestyle should consist of
is not only a philanthropic act, but also an economic one. 
Effects of a Polyphenols-Enriched Chardonnay French White
Wine and a Sparkling Pinot Noir Brazilian Red Wine on
Early Atherosclerosis in Hamsters
C. Auger‡¶, J-M. Rouanet‡, R. Vanderlinde†, , A. Bornet¶,
P. Gerain‡, N. Lequeux, J-P. Cristol, P-L. Teissedre*(#)
‡ Equipe d’Accueil 3762, Nutrition & Aliment, Université Montpellier 2, Place
Eugéne Bataillon, 34095 Montpellier, France.
† Universidade de Caxias do Sul, Instituto de Biotecnologia, Rua Francisco
Getúlio Vargas, 1130. CEP 95070-560 – Caxias do Sul – RS. Brasil.
 Equipe d’Accueil 2993, Nutrition Humaine & Athérogénèse, Université
Montpellier 1, CHU La Peyronie, 34925 Montpellier, France.
¶ UMR 1083 INRA Sciences pour l’Œnologie, Centre d’Œnologie, Faculté de
Pharmacie, 15, Av. Charles Flahault, B.P. 14491, Université Montpellier 1,
34093 Montpellier, France.
[E-mail : pteissed@univ-montp1.fr]
Tel: 33 (0)4 67 54 86 74, Fax: 33 (0)4 67 54 86 86
The aim of this work was to assess the protective effect on early
atherosclerosis in hamsters of 2 different specific wines : a
polyphenols enriched chardonnnay french white wine (PCWW)
produced by Virginie-Castel and a sparkling pinot noir brazilian
red wine (SPRW) produced by Chandon do Brazil in comparison
with a solution of ethanol 12% vol. (A), or only water (W). These
2 wines contains total phenols (expressed in gallic acid equivalent)
: 1425 mg/L for PCWW and 570 mg/L for SPRW. Levels of
Tanins (catechin, epicatechin and procyanidins dimers :
B1,B2,B3,B4) were 371.9 mg/L for PCWW. Contents of
Catechins and anthocyanines monomers was 217.4 mg/L and
272.1 mg/l for red polymers in SPRW. Hamsters fed an athero-
genic diet for 12 weeks. Four groups of 8 hamsters fed such a diet
received by force-feeding PCWW, SPRW or A mimicking a mod-
erate consumption of wine (500mL/Day/70kg Adult Body
weight). Controls (W) received water. After 12 weeks of feeding
and 18 h of food deprivation, the hamsters were anesthetized.
Plasma apolipoprotein A-1 (Apo A-1) and apolipoprotein B (Apo-
B) concentrations were determinated using Sigma turbidimetric
immunoassay kits. The plasma antioxidant capacity (PAC) in
hamsters fed the atherogenic diet was measured using a kit from
Randox Laboratories. The aortic arches were carefully dissected
and lipids stained with Oil red O. Each aortic arch was then direct-
ly displayed on a glass slide, endothelium side up and observed en
face by light microscopy. All segments were photographed using
a video digitizer. The area covered by foam cells (aortic fatty
streak lesion) was analyzed quantitatively using a computer-assist-
ed morphometry system and expressed as a percentage of the total
area surveyed. Cholesterol levels were reduced significantly for
PCWW and SPWR groups. The ratio Apo-A1/Apo-B increased in
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SESSION VII: Wine, the Metabolic Syndrome and Degenerative Diseases
Wine and the Mediterranean Diet’s Protection Against the
Metabolic Syndrome is Mediated by Endothelial Nitric Oxide
Synthase
Federico Leighton (Keynote Speaker)
Laboratorio de Nutrición Molecular, Universidad Católica de Chile, Casilla 114-
D, Santiago, CHILE
[E-mail: fleighto@bio.puc.cl], www.pam-chile.cl
The positive health effects derived from moderate wine con-
sumption are pleiotropic. They appear as improvements in car-
diovascular risk factors such as plasma lipids, haemostatic mech-
anisms, endothelial function, and antioxidant defences. The
active principles would be ethanol and mainly polyphenols.
Results from our and other laboratories, support the unifying
hypothesis that the improvements in risk factors after red wine
consumption are mediated by endothelial nitric oxide synthase
(eNOS). Many genes are involved, but the participation of eNOS
would be a constant feature. In cells in culture, red wine enhances
both, function and expression of eNOS in a process dependent on
phenolic antioxidants and largely regulated at the transcriptional
level. In vivo, both mediterranean diets and red wine enhance
endothelial function in human volunteers. It has also been shown
that eNOS mediates the antithrombotic effect of red wine. The
metabolic syndrome is a cluster of metabolic risk factors associ-
ated to high risk of cardiovascular disease (CVD). The National
Cholesterol Education Program’s Adult Treatment Panel III
(NCEPATP III) clinical definition of the metabolic syndrome
requires the presence of at least three risk factors, from among
abdominal obesity, high plasma triacylglycerols, low plasma
HDL, high blood pressure, and high fasting plasma glucose. The
molecular mechanisms responsible for the metabolic syndrome
are not known. Much emphasis has been given to insulin resis-
tance. Also oxidative stress does play a role, and oxidative dam-
age in metabolic syndrome has been described and was also
found in our observations. Since metabolic syndrome apparently
affects 10 to 30% of the population in the world, research on its
pathogenesis, molecular mechanisms and possible therapeutic
and preventive measures, is needed. The recent finding that eNOS
knockout mice present a cluster of cardiovascular risk factors
comparable to those of the metabolic syndrome, suggests that
defects in eNOS function may cause human metabolic syndrome.
These mice are hypertensive, insulin resistant and dyslipidemic.
Further support for a pathogenic role of eNOS comes from the
finding in humans that eNOS polymorphisms associate with
insulin resistance and diabetes, with hypertension, with inflam-
matory and oxidative stress markers, and with albuminuria.
Epidemiological studies as well as recent intervention studies,
provide evidences that mediterranean diets and wine consump-
tion are associated with reductions in metabolic syndrome car-
diovascular risks. Moreover, it has been observed that light to
moderate alcohol consumers show a favourable insulin profile,
when compared with non-drinkers and heavy drinkers. From
recent studies addressing directly the relationship among alcohol
consumption and the prevalence of metabolic syndrome, in
Sweden and USA, it can be concluded that moderate alcohol con-
sumption is significantly and inversely associated with metabolic
syndrome, as shown for several of its components: low serum
HDL cholesterol, elevated serum TAGs, high waist circumfer-
ence, hyperinsulinemia, and hypertension. It has also been shown
in recent trials of mediterranean diet, in patients with the meta-
bolic syndrome, a decrease in vascular inflammation markers and
an improvement in endothelial function. So, the overall data sus-
tain the hypothesis that eNOS enhancement should reduce meta-
bolic syndrome incidence and its consequences. Therefore red
wine and mediterranean diets, since they improve endothelial
function in volunteers, and enhance eNOS function in vitro, pre-
sumably a consequence of their high content of phenolic antioxi-
dants, should be considered as potential tools for the control of
metabolic syndrome. Initial results from other groups, support
our proposal.
Alcohol, Wine and the Skeleton
F.S. Hough
Endocrine Unit, Department of Medicine, Faculty of Health Sciences,
Stellenbosch University: Tygerberg Academic Hospital, PO Box 19063,
Tygerberg 7505, South Africa
[E-mail: fsh@sun.ac.za]
Osteoporosis is a common, costly and serious disorder charac-
terised by a low bone mineral density (BMD), increased bone
fragility and susceptibility to fracture, which typically involves
the wrist, spine or hip. Osteoporosis involves one in four post-
menopausal women and one in six men. Up to 20% of hip frac-
ture patients die within one year of the event. Even more discon-
certing is the fact that less than 50% of patients are capable of
leading an independent life following a hip fracture. The direct
medical costs of acute fracture care in the USA exceeds $15 bil-
lion per year. A decrease in bone mass (BMD) and strength is
generally the result of either genetic, environmental and/or age-
ing factors. Up to 70% of the variation in peak bone mass is
genetically determined. Genetic factors are also involved in the
age-related decrease in bone mass and in BMD-independent fac-
tors which predispose to fracture. Age-related factors largely
involve the acute decrease in serum oestradiol levels following
the menopause (  bone resorption), and osteoblast incompetence
with ageing (  bone formation). Environmental factors include
diseases/drugs and life-style changes (diet, physical inactivity,
smoking, alcohol) known to adversely influence bone.
the group receiving Alcohol A (significantly) and with both wines
SPWR and PCWW indicating a potential beneficial effect. Plasma
antioxidant capacity was increased significantly in the groups A
and SRPW compared with controls. Aortic fatty streak area was
significantly reduced in the groups receiving SPRW (-85%),
PCWW (-85%) and A (-58%) in comparison with controls. Our
findings demonstrate that chronic ingestion (nutritional moderate
consumption) of a polyhenol enriched white wine (rich in cate-
chins) prevent the development of atherosclerosis in hamsters the
same way that a red wine (containg anthocyanines and catechins).
The phenolic compounds family involved in such a beneficial
effect can be attributed to the catechins – tanins family.
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The Acute Influence of a Mediterranean-like Diet With and
Without Red Wine on Patients With the Metabolic Syndrome
D.P. Van Velden1, E.P.G. Mansvelt1, S. Van der Merwe1,
E. Fourie1, D.M. Blackhurst2
(1) University of Stellenbosch Faculty of Health Sciences PO Box 19063,
Tygerberg 7505, South Africa.
(2) Cape Heart Centre, University of Cape Town Faculty of Health Sciences,
Anzio Road, Observatory 7925, South Africa.
[E-mail: dpvv@sun.ac.za]
This study examined whether a Mediterranean-like diet comple-
mented with red wine and mild exercise had an acute impact on
patients diagnosed with the metabolic syndrome. In this study, 12
patients between the ages 32 to 60 years with the metabolic syn-
drome, consumed a Mediterranean-like diet for 4 weeks respec-
tively with and without red wine. During the experimental peri-
ods the subjects increased their intake of vegetables, cereals, fruit,
mono-unsaturated fatty acids and fish at the expense of red meat
and dairy products. Patients were motivated to include 20 – 30
minutes of mild exercise (walking) into their daily routine.
Dietary control was through 4 times 3-day dietary record during
the study period. A genetic screen was done on all participants for
genetic markers of cardiovascular disease (CVD). Weight, BMI,
abdominal circumference and blood pressure were measured at
each visit. Fasting blood samples were taken at base line, after the
diet and after the diet plus wine periods. The following biochem-
ical parameters were determined at baseline, after 4 weeks of diet
and after another 4 weeks of diet plus moderate red wine con-
sumption: total cholesterol(TC), triglycerides(TG), HDLC,
LDLC, TC/HDL ratio, uric acid, fasting blood glucose, insulin,
and the glucose/ insulin ratio. Hypersensitive C-reactive protein
(HS-CRP), FVIII, fibrinogen and von Willebrand’s factor (vWF)
were measured as inflammatory markers. The haematological
parameters measured were: platelet count, platelet coagulation,
platelet membrane fluidity, plasma TxB2, tPA, PAI-1, FVII,
FVIII, fibrinogen, and vWF. The oxygen radical absorbent capac-
ity (ORAC) was determined to measure the antioxidant effect of
the diet and wine intervention. There was a statistical significant
(p=0.044) increase in the ORAC after the experimental period.
Body weight decreased significantly (p=0.0403), and a trend in
decrease in the abdominal circumference (p=0.059) was ob-
served. A statistically significant decrease in systolic blood pres-
sure (p=0.0446) was observed. This study indicates that diet can
reduce weight and blood pressure, but do not influence the
arherogenic lipoprotein and pro-coagulent haematological profile
in patients with the metabolic syndrome on the short term. Red
wine had no additional benefits during this short intervention
period. It appears that wine consumption is rather a biological
marker of a healthier lifestyle pursued by its devotees than an
actual cause of superior health per se.
THEME: Nutrition, Lifestyle, Wine and Health Relationships
SESSION VIII: Mediterranean Diet and Wine
Mediterranean Diet, Wine in Moderation, and Health
Antonia Trichopoulou (Keynote Speaker)
Department of Hygiene and Epidemiology, University of Athens, Medical School,
Mikras Asias 75, Goudi 11527, Athens, Greece
[E-mail: antonia@nut.uoa.gr] 
In my presentation, I will consider first what is the Mediterranean
diet and what is the role of the Mediterranean wine drinking pat-
tern. Next, I will present evidence indicating how Mediterranean
diet, that integrates moderate alcohol consumption, affects longevi-
ty in a clearly Mediterranean country, Greece. Subsequently, I will
provide data that a Mediterranean- inspired diet can be beneficial
even for people living outside the Mediterranean region. I will pre-
sent data supporting Mediterranean diet, including moderate wine
consumption, as an appropriate diet for those who have already suf-
fered a coronary attack. I will conclude with examination of the
role of moderate wine drinking in the Mediterranean diet and the
associated longer survival.
Alpha-Linolenic Acid in the Prevention of Coronary Artery
Disease and Arrhythmia: What’s New from the Lyon Study?
D. Lanzmann-Petithory and S.C. Renaud
Centre Hospitalier Emile Roux, Assistance Publique des Hôpitaux de Paris. 
1 avenue de Verdun, 94456 Limeil-Brévannes Cedex France
[E-mail: dominique.lanzmann@erx.ap-hop-paris.fr.]
The low mortality rate in the Cretan cohort of the 7 country study
was in relation with a high plasma level of the precursor of the
omega 3 fatty acid (FA) family : alpha-linolenic acid (ALA) com-
ing from an ALA rich food chain. In the duplication of the Cretan
diet on 600 coronary patients, we replaced butter and oils by rape-
seed oil and rapeseed margarine, rich in ALA. We did not observe
any sudden death as compared to 10 in the control group with the
prudent diet. Singh confirmed recently this results, with mustard
seed oil. He observed 6 sudden cardiac death, versus 16 in the
control, and 8 versus 30 other non-fatal ventricular arrhythmia
(ventricular ectopics 8/min). Comparing the intervention trial
with fish or fish oil omega 3, and plant omega 3 : RR of cardiac
death = 0.7 (DART), 0.8 (GISSI), 0.24 (Renaud) and 0.33
(Singh). RR = 1.26 in the last study of Michael Burr with fish or
fish oil, unexplained results, RR of sudden death being 1.54, sig-
nificant. Animal studies have confirmed that ALA supplied under
the form of rapeseed oil, was the most efficient FA to reduce vul-
nerability to cardiac arrhythmia in rats. The mechanism of the
antiarrhythmic effects of omega 3 FA, in normal and Ca2+ over-
loaded cells, appears to be primarily by reducing the Ca2+ entry.
A daily consumption of 2 grams of ALA is central in a healthy
diet ( 2 spoons of rapeseed oil or mustard oil a day).
Oil and Olive Health
Nola Dippenaar
Fat is an important component of the daily diet of humans, and
recent research has clearly illustrated that it is not the quantity of
fat taken in daily, but the type of fat consumed that is vital for
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health. Over the past decades, due to the high incidence of car-
diovascular disease, the general recommendation was to limit the
intake of fat, in particular the intake of saturated fat, and to
replace this with carbohydrate. This inevitably led to a greater
intake of refined carbohydrates, which wrecks havoc with glu-
cose and insulin levels in the human body. More recently the
Mediterranean Diet and lifestyle of the people of Crete became
the recommended lifestyle to follow, with the food pyramid sym-
bolizing the best and worst choices in daily nutrition. From the
ongoing research in this area, it once again became apparent that
the recommended 30% of daily energy intake in the form of fat
should not be reduced, but rather better balanced, with saturated
fat supplying no more than 10%; the bulk in the form of mono-
unsaturated fat (10-15%) and the remainder as polyunsaturated
fat (omega 3 and omega 6). This would also ensure that the daily
intake of cholesterol was below the recommended level of 300
mg/day.
Omega-6 vs Omega-3 Fatty Acids: The Margarine Debacle
C.F. Albrecht
Research Advocate: Cancer Association of South Africa, 15 Antoinette Street,
Amanda Glen, Durbanville 7550, South Africa
[E-mail: calbrec@iafrica.com]
Margarine is a major human innovation whereby plant oils and
fats are converted to a semi-solid spread which has been con-
sumed on a large scale at the expense of unhealthy animal fats in
butter and lard that were clearly shown to enhance the risk of
heart disease. Unfortunately margarine has two main intrinsic
lipid flaws, i.e. the presence of trans-fats formed during the
hydrogenation process and the relative absence of omega-3 fatty
acids due to inappropriate choice of plant oils. Evidence exists
that systemic inflammation is involved in the etiology of diseases
such as atherosclerosis and cancer. Much of this inflammation is
programmed by the activation of the NF-kappaB transcription
factor, which in turn actives a host of pro-inflammatory genes.
PPARgamma is another transcription factor, which when activat-
ed can inhibit NF-kappaB. In normal cells PPARgamma should
be active and NF-kappaB inactive. Trans-fats inhibit
PPARgamma; omega-6 fatty acids activate NF-kappaB, omega-3
fatty acids stimulate PPARgamma and saturated fats activate NF-
kappaB. Resveratrol from red wine inhibits NF-kappaB. It fol-
lows that too much trans-fats and omega-6 fatty acids can under-
mine health by inducing systemic inflammation, whereas an
absence of trans-fats and a close to parity ratio of omega-6 to
omega-3 fatty acids could enhance health by keeping NF-kappaB
dormant. This lipid imbalance is referred to as the “margarine
debacle” in this document. Fortunately more modern margarines
have been manufactured which are trans-fat free and have ratios
of omega-6 to omega-3 less than 10:1. Legislation is needed to set
the norms for healthy margarine. It is predicted that future mar-
garines will act as vehicles not only for beneficial lipids but also
for many different natural products, over and above vitamins,
such as resveratrol and curcumin – both of which are potent
inhibitors of NF-kappaB.
SESSION IX: Alcohol and Health: Is Wine really Good for You?
From French Paradox to Cretan Miracle
S. Renaud (Keynote Speaker)
When I first arrived in Canada in 1951 to continue my college
education, I was struck by the high proportion of heart attacks
suffered by young hockey players and the population at large. The
origin could not be genetic since the inhabitants of Quebec share
the same genetic characteristics as the French. Therefore, an envi-
ronmental factor had to be responsible. I observed the huge dif-
ference in eating habits, especially the large consumption of sat-
urated fats, the very small consumption of fruit and the absence
of wine compared to the Bordeaux region I was from where one
gladly brought a good bottle of wine to a hospitalized relative. In
those years, the only way to study nutrition was to embark on vet-
erinary studies since nutrition was not taught to future doctors.
After finishing first in my class at the Veterinary College, I chose
to devote myself entirely to research. I started my career with
Hans Selyé, the inventor of “stress,” who wanted me to become
his main assistant, but I preferred to study the relationship
between nutrition and coronary heart disease. Indeed, the war
years had shown the astonishing reduction in thrombosis in peri-
ods when food is scarce and less rich in saturated fat. I was con-
vinced that the quality of fats was a major factor determining
health. I was quickly promoted to a post-graduate teaching posi-
tion and became Professor of pathological anatomy and Professor
of nutrition at the Medical School of Montreal. My experience in
pathological anatomy at the Cardiology Institute of Montreal and
experimental studies in rat confirmed to me the major role played
by thrombosis in myocardial infarction, independent of choles-
terol, thirty years before it became fashionable. After years of lab-
oratory research on the nutritional factors responsible for throm-
bosis, I developed a method of research on platelet activity in
humans: reaching rural populations thanks to a laboratory on
wheels. The study of the behaviour of blood platelets requires
delicate and immediate analyses and it would have been vain to
imagine rural populations travelling to research laboratories. In
this way I was able to compare different regions of Western
Europe (Moselle, Var, Belgium, Wales, Scotland) and put these
populations on diets based on rapeseed oil. I thus proved that
platelet aggregation was the factor most closely linked to coro-
nary disease and demonstrated the effects of alpha-linolenic acid
(omega 3) on the lowering of platelet aggregation. Everything
was ready to organize the Lyon diet heart study on the Cretan
diet, which was confirmed in 2002 by an Indo-Israeli study. In
this study, I demonstrated that the Cretan secret was not in their
siestas, nor in their genes, but in their diet. Olive oil is not the key.
Their eating habits, dating back at least thirty-five centuries, are
responsible for their low level of cardio-vascular disease, a twen-
tieth of that experienced elsewhere. Wild greens on the island are
the starting point of a traditional food chain. They naturally
enrich animal products and by-products with esential fatty acids.
The inhabitants’ plasma is three times richer in alpha-linolenic
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acid, the precursor of the family of omega 3, than in other
European countries. It is said to be essential because it cannot be
synthesized. The Lyon diet heart study showed that in adding this
fatty acid to the diet of heart patients (1.3 grams a day more than
in the control group), 75% of coronary recurrences and 100% of
sudden deaths were prevented. Yet, after a six-month follow up
period, the cardiologist in charge of monitoring the patients want-
ed to change their diet, unconvinced of its usefulness because
their cholesterol level did not get down! I refused to modify the
programme, which represented the culmination of thirty years of
deductions, and I was vindicated by the unprecedented results. It
is easy to have a diet rich in alpha-linolenic acid. One need only
use rapeseed oil in cooking and seasoning. Two soup spoons of
rapeseed oil contain 1.8 grams of alpha-linolenic acid, or 100%
of the recommended daily intake. While I was visiting professor
at Boston University, I learned of the results of the Framingham
study in which alcohol, supposedly a harmful factor in coronary
heart disease, seemed, on the contrary, to protect from it, this to
the huge astonishment of the epidemiologists at the N.I.H.
(National Institute of Health). The information was wilfully kept
secret for several years but I considered it extremely important as
it could partially explain the cardio-vascular protection of the
French. I then launched studies of alcohol and wine in animals in
the framework of my research on thrombosis before embarking
on research on humans in Wales. In 1991 while I was working on
several studies, journalists from 60 Minutes, the CBS television
programme, came to my laboratory, Unit 63, in Lyon, to ask me
my opinion on the cardio-vascular protection of the French. I sug-
gested, taking great precautions, that alcohol could be one of the
protective factors. The expression, the French Paradox, was heard
on the air for the first time in the U.S. during this interview on the
famous 60 Minutes programme. At the request of thousands of
Americans, it was re-broadcast several times and watched by
more than fifty million Americans. A direct consequence of this
highly successful programme was that the U.S. government
(Federal Bureau of Alcohol, Tobacco and Firearms) asked me to
justify my words in a request made through the French Ministry
of Finance. It was then that I published an article in the Lancet in
which I explained my reasons. Following the appearance of this
article, I never received any other requests from the American
government. However, two years later, the U.S. Surgeon General
suggested that a moderate intake of alcohol could be beneficial to
health. In the 1992 Lancet article, I thus defined the French
Paradox : for a level of risk factors similar to that of countries
such as England and the U.S. (cholesterol, high blood pressure,
smoking, saturated fat consumption), France has a lower coro-
nary heart disease mortality rate than in the majority of the rest of
the industrialized world. I then developed my hypothesis that the
habit of drinking moderate amounts of wine with meals could be
beneficial to health, an hypothesis backed up by numerous obser-
vation studies. I continued to study this concept both in animals,
in particular on the positive role of alcohol on blood platelets and
especially wine, in the prevention of the platelet rebound effect
and in humans. Over ten ago, I launched a vast epidemiological
population follow-up study with the Center of Preventive
Medicine in Nancy. Thanks to this institution and to the head of
statistical programmes, René Guéguen, we have been able to
gather data on 100,000 subjects over a 20 – 25 year period. This
study consists in monitoring the causes of death since 1978 of a
group of 45,000 men and 55,000 women aged now between sixty
and ninety and whose drinking habits and main biometric and
biological health parameters are known from the beginning. It
was the first study in France to have demonstrated that a moder-
ate consumption of alcohol, particularly wine, was associated
with a 40% reduction in cardio-vascular mortality in middle-aged
men. The analysis of this group showed, for the first time, that a
daily intake of between 1 and 3 glasses of wine, and only wine
among alcoholic beverages, was linked to a 20% reduction in
death from cancer. These surprising results were confirmed in
Denmark. The conclusions of Gronbaeck are similar to ours :
only wine in moderate amounts is associated with a reduction in
deaths from all causes including cancer. Beer does not have the
same effects, especially concerning deaths from cancer. This
regional French group is one of the few in the world (2 or 3) com-
prising enough subjects to be broken down into sub groups com-
posed of only moderate wine drinkers and thus able to differenti-
ate the consequences of moderate wine drinking from other alco-
holic beverages on mortality. The Eastern region of France pre-
sents the particularity of having both an important group of wine
drinkers and also beer drinkers. Until now only the results of
studies on humans have been able to be published on deaths from
all causes and from cancer as well as on deaths related to high
blood pressure. Today, my work is now continued by Dr
Dominique Lanzmann-Petithory, who takes over all the pro-
gramme of the Nancy study. We are looking for funding in order
to continue this study. Recently, in March 2005, American friend
cardiologists under the guidance of Dr Tedd Goldfinger made me
the honour to create the Renaud Society http:www.renaudsoci-
ety.com, an association of physician passionate about wine and
research on wine. The association was launched at the Culinary
Institute of California on Saturday, 5 March 2005, in the presence
of my friends Morten Gronbaeck, Curtis Ellison, François de
Booyse and Arthur Klatsky (from right to left on the photograph).
Deleterious Influence of Wine on the Human Dentition
U.M.E. Chikte
University of Stellenbosch, Faculty of Health Sciences, PO Box 19063, Tygerberg
7505, South Africa
[E-mail: umec@sun.ac.za]
The purpose of the study was to investigate the erosion effect of
wine on human teeth using multidimensional research approach-
es involving epidemiological tools, Microhardness tests,
Scanning Electron Microscopy (SEM) and Confocal Laser
Scanning Electron Microscopy (CLSM). Differences in erosion
between teeth of wine-makers and those who are not wine-mak-
ers, was clearly demonstrated. The continuous, frequent exposure
of wine-makers’ teeth to wine is the major factor in the differ-
ences obtained. Microhardness tests and microscopic investiga-
tions conducted confirmed the deleterious influence of enamel
exposed to wine. A clear ‘dose-response’ relationship was
demonstrated by means of the Microhardness tests. Differences
were also demonstrated in the surface morphology of enamel
with respect to the exposure to the wines investigated in the SEM
and CLSM studies. Differences with respect to severity were
shown with the SEM investigations. Subsurface lesions were
observed with the aid of CLSM on the enamel exposed to the
wines.
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The Importance of Food Allergens in the Liquor Industry
H. Steinman (Keynote Speaker)
FACTS: Food & Allergy Consulting & Testing Services, P.O. Box 565, Milnerton,
Western Cape.
[Email: harris@factssa.com]
Early recorded history documents the addition of various sub-
stances to food for a variety of technical reasons. These include
salt, sugar and vinegar for food preservation, and sulphur dioxide,
which was used during the Roman era for sterilisation of wine
vats. Today there are more than 20,000 additives available that
can be utilised in food for a variety of technical grounds. Usually
the intake of these is small. A number of additives are utilised in
the manufacture of various types of liquor. Many of these are
sourced from foods that have well-documented allergenic poten-
tial, for example, egg when used as a clarifying agent. The result-
ing additive may retain the allergenic potential of the original
substrate and consequently the manufactured food may contain a
‘hidden’ allergen. Furthermore, a number of substances are
formed or altered during the manufacturing process, e.g., hista-
mine. These may result in non-allergenic intolerance effects in
individuals. Some substances, such as alcohol, even when not
abused, may result in a variety of adverse effects depending on
the pathophysiological mechanism. For example, approximately
45% of oriental individuals have a partial to complete absence of
a vital enzyme required for the metabolism of alcohol. Examples
of allergens and additives that may be found in the liquor indus-
try of which a number may result in adverse effects in individu-
als are: Alcohol, Barley, Egg, Grape, Histamine, Hops, Isinglass,
Nitrates, Sulphur dioxide, Tyramine, Wheat and Yeast. Further, a
number of allergens, such as mites and moulds, may affect work-
ers in occupational settings. Adverse effects may be confined to
oral and gastrointestinal effects, but in occupational settings,
‘inhalant’ allergens may result in respiratory symptoms and may
be vitally important for the well-being of workers. Understanding
the importance of additives or natural ingredients that have been
implicated in adverse reactions, whether exerting their adverse
effects due to an allergic or intolerance mechanism, will result in
a deeper understanding problems experienced by consumers and
workers in the industry.
What about Biogenic Amines, Ochratoxin A etc.
M du Toit1, L Downing1, K Le Grange-Nel2, M Lambrechts2
(1) Institute for Wine Biotechnology, Department of Viticulture and Oenology,
Stellenbosch University, Matieland, 7602, SOUTH AFRICA
(2) Distell, Adam Tas Road, Private Bag 184, Stellenbosch, 7599, SOUTH
AFRICA
[E-mail: mdt@sun.ac.za]
It is generally accepted that moderate wine drinking can be benefi-
cial to human health. However, some unwanted compounds, includ-
ing potential carcinogens, such as ethyl carbamate, mycotoxins such
as ochratoxin A, neurotoxins, such as biogenic amines, and asth-
matic chemical preservatives, such as sulphites, can sometimes also
be found in wine. Biogenic amines are basic nitrogenous low mole-
cular weight compounds with biological activity that may be formed
or catabolised during the normal metabolism of animals, plants and
micro-organisms. Biogenic amines are derived mainly from amino
acids through substrate-specific decarboxylase enzymes. Amines
may be formed by yeasts during the alcoholic fermentation (mostly
putrescine); by lactic acid bacteria (LAB) during malolactic fer-
mentation (MLF) and during maturation of wines. Biogenic amines
can also be present in the must, such as putrescine in grapes is asso-
ciated with potassium deficiencies in the soil. The main biogenic
amines in wine are histamine, tyramine, putrescine, cadaverine and
phenylethylamine. In view of this certain countries/supermarkets
are imposing upper legal levels of histamine in wines. To elucidate
the current situation in South African wines a twofold strategy was
followed. Firstly, the biogenic amine-producing ability of 400 lactic
acid bacteria (LAB) isolated from South African wine was deter-
mined, using a decarboxylase screening plate method. Tyramine
was the main amine formed by the LAB strains investigated.
Putrescine was also produced. Lactobacillus hilgardii strains were
shown to be mainly responsible for biogenic amine formation. Two
Lactobacillus brevis strains also produced biogenic amines. None of
the LAB produced histamine or cadaverine. The effect of tempera-
ture and pH on the formation of biogenic amines were also tested.
Secondly, 300 commercial South African wines were tested for the
presence of histamine, tyramine, putrescine and cadaverine. A low
percentage of wines contained concentrations higher than the sug-
gested levels. Fungi can produce mycotoxins, which are regarded as
Alcohol, Wine, Hypertension (HTN) & Coronary Heart 
Disease. (CHD)
A.L. Klatsky
Senior Consultant in Cardiology, Kaiser Permanente Medical Care Program,
Oakland, California, USA
Since wine is an alcoholic beverage, the theme of this session and
of this presentation needs to focus on the relative role of beverage
choice (wine, liquor, or beer) in the relations to health measures
or outcomes. Thus, “good for you” translates into “better for you”
where alcohol drinking (usually light-moderate) is beneficial or
“less bad for you” when alcohol drinking (usually heavy) is
harmful. This dichotomy is illustrated well by relations to HTN
and to CHD. Ecological studies provide strong evidence that wine
drinkers fare better than beer or liquor drinkers with respect to
CHD risk and some cohort studies contribute to this hypothesis.
All available outcome data are from observational studies.
Possible residual confounding by drinking pattern, diet, physical
activity, behavioral traits, or psychosocial factors cannot yet be
completely ruled out. Issues include: 1) How appropriate is infer-
ential assumption of confounding? 2) How appropriate is infer-
ence of benefit via non-alcoholic wine ingredients? 3) How might
a satisfactory randomized prospective controlled clinical trial be
designed and executed?
SESSION X: Healthy Wine Production
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carcinogens, and thus a matter of great concern with consumers.
Therefore discussions are ongoing in the European Union to estab-
lish maximum limits for the presence of Ochratoxin A in wine. The
two genera of fungi associated with infected grapes that can produce
these mycotoxins (such as aflatoxins, patulin and ochratoxin A) are
Aspergillus and Penicillium. It is therefore important to evaluate the
levels of ochratoxin A in wine to establish a base line level. Ethyl
carbamate received much attention in 1970’s when high levels was
detected in fruit distillates and brandies destined for Canada. Ethyl
carbamate levels can be influenced by physical parameters during
ageing and storage of wine or by the yeast and bacteria. These two
wine microorganisms have different mechanisms to produce this
compound. The amount of ethyl carbamate produced by yeast is
mostly negilible, but a study conducted by Uthurry et al. in 2005
showed the levels increased significantly after MLF, irrespective of
the starter culture used. Today there are also legal limits for the level
of ethyl carbamate for different wine styles.
Organic Viticulture and Winemaking in South Africa
D.R.A Wilson
Stellar Winery, PO Box 4, Klawer, 8145
[E-mail: dudley@stellarorganics.com]
This paper deals with all aspects of Organic wine from definitions,
methods of organic viticulture, production in the cellar to the mar-
keting and sale of organic wine. There are as many definitions as
certifying bodies but they all have at their core the production of a
crop without the use of synthetic chemicals. The organic wine defi-
nition is not as clear cut, as a distinction can be made between 100%
organic and “Wine made from organically produced grapes”.
Production of organic grapes is really about controlling fungal dis-
eases so it makes sense that most of the larger organic farms are in
the warmer drier areas. This presents problems with an activity
common to most organic farms: compost making. Strategies in the
vineyards have been developed to make compost making unneces-
sary. Organic substitutes have been developed for most chemicals
used conventionally. The problem is that does one want a total
destruction of pests and diseases or does one want to develop a nat-
ural balance that obviate the need for a spray, organic or not.
Organic vineyards are often more expensive to establish, but once a
balance has been achieved, the production costs fall below conven-
tional production. In the cellar there are not as many enforced rules
as might be imagined. The most obvious and the easiest to test is the
Sulphur dioxide level. Strategies must be developed to bottle the
wine with the correct amount of SO2 to ensure a normal shelf life
whilst still coming below the 80-100ppm total limit. This invariably
means not using much SO2 early in the process. This can have an
impact on wine style and the production of biogenic amines. Self
enforced restrictions include the avoidance of fining agents from
eggs, gelatine, fish etc. This is to cater for the significant numbers of
vegetarian customers who are attracted to organic wines assuming
they will not have these in them in the first place. There are no
restrictions on the packaging for organic wines. The certifier is inter-
ested in the product and not the packaging. Most producers are
mindful of the connection in people’s minds between organic prod-
ucts and traditional production. Plastic closures, allowed for organ-
ic wines, are generally avoided as their image does not sit well with
traditionalists or environmentalists. Organic wines producers should
take care not to create too separate an image from conventional
wines. It is possible to saturate the dedicated organic consumer. Real
growth will come from normal wine drinkers who choose organic
because the price, quality, image combination is right. It is difficult
to justify that drinking organic wine is healthier than conventional
or that organic wines will always taste better. They should also be
realistically priced as consumers automatically expect organic pro-
duce to be more expensive. Organic wine production is undoubted-
ly more environmentally friendly and with more and more people
trying to live healthier lives, the presence of organic wines on
shelves or on wine lists helps them to fulfil their chosen lifestyle.
Scheme for the Integrated Production of Wine as a Consumer
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A. Tromp1, L. Van Schoor2, E. Allsopp3
Scheme for the Integrated Production of Wine, The Wine and Spirit Board,
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Tel: +27 21 8093007 - Fax: +27 21 8093584
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The Scheme for Integrated Production of Wine was introduced in
South Africa in 1998. Fifteen guidelines for production of grapes
and 13 for production of wine form the technical base of IPW.
Compliance with guidelines is evaluated by producers and wine-
makers themselves, and audited by ARC Infruitec-Nietvoorbij
and Enviroscientific Auditing Services on a spot check basis.
Evaluation of the agrochemical spray records is based on IP co-
ding of registered agrochemicals, which assesses the environ-
mental impact of each product. This system enables producers to
minimize the environmental impact of agrochemical applications
by selecting the products and application methods that are least
detrimental to the environment.
Wine, Lifestyle, and Health
R.C. Ellison (Keynote Speaker)
Section of Preventive Medicine & Epidemiology, Department of Medicine,
Institute on Lifestyle & Health,
Boston University School of Medicine, Boston, MA – USA
Epidemiologists have known for several decades that the moderate
consumption of alcohol is associated with less coronary heart dis-
ease (CHD). In 1974, after the Framingham Heart Study had been
in operation for more than 25 years, a report on the factors related
to deaths from coronary heart disease (CHD) was prepared. It con-
tained strong evidence that individuals who smoked cigarettes, had
high levels of blood cholesterol, and/or had high blood pressure
were much more likely to die from CHD. These became known as
major “risk factors” for heart disease. In the same paper prepared by
the Framingham Study investigators, there were also data showing
a marked reduction in the risk of CHD mortality for consumers of
alcohol. Because officials at the National Institutes of Health feared
that releasing the latter information would lead to increased alcohol
abuse in the US, they required that the alcohol-CHD data be
removed, and the fourth major risk factor, “abstinence from alco-
hol,” was omitted from the paper. Many other scientists, however,
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began to publish information showing an inverse association
between alcohol intake and CHD, with reports coming from studies
by Arthur Klatsky in California and from around the world. The
number of publications on moderate drinking increased markedly
after the 60 Minutes program on the “French Paradox” in 1991,
when the American public first became aware of potential beneficial
aspects of alcohol. At the same time, many scientists apparently felt
that it was now “politically correct” to report data demonstrating
beneficial health effects of alcohol. Of hundreds of studies pub-
lished in the scientific literature over the past decade, the results
have been amazingly similar: almost uniformly, they have demon-
strated that moderate drinkers have much less CHD. And new data
show that, for people who already have CHD, moderate alcohol
intake reduces the chances of repeat angioplasty and death.
